For: | Selvaraj V, Lal A, Finn A, Tanzer JR, Baig M, Jindal A, Dapaah-Afriyie K, Bayliss G. Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease. World J Crit Care Med 2022; 11(1): 48-57 [PMID: 35433306 DOI: 10.5492/wjccm.v11.i1.48] |
---|---|
URL: | https://www.wjgnet.com/2220-3141/full/v11/i1/48.htm |
Number | Citing Articles |
1 |
Effat Davoudi-Monfared, Arezoo Ahmadi, Elahe Karimpour-Razkenari, Bita Shahrami, Farhad Najmeddin, Mojtaba Mojtahedzadeh. Remdesivir Administration in COVID-19 Patients With Renal Impairment: A Systematic Review. American Journal of Therapeutics 2022; 29(5): e520 doi: 10.1097/MJT.0000000000001543
|
2 |
Sonal Singh. Medication safety in chronic kidney disease. Current Opinion in Nephrology & Hypertension 2023; 32(5): 434 doi: 10.1097/MNH.0000000000000907
|